Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BANK OF AMERICA CORP /DE/ (BAC)

  • SEC News
  • April 21, 2026, 15:18 UTC
  • 2
  • 0 comments

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001918704-26-010388 <b>Size:</b> 648 KB

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 21, 2026, 15:17 UTC
  • 2
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001193125-26-166207 <b>Size:</b> 739 KB

Comment Full text

UBS AG (LONDON BRANCH) (MVRL)

  • SEC News
  • April 21, 2026, 15:16 UTC
  • 2
  • 0 comments

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001839882-26-020762 <b>Size:</b> 562 KB

Comment Full text

HERON THERAPEUTICS, INC. /DE/ (HRTX)

  • SEC News
  • April 21, 2026, 15:15 UTC
  • 2
  • 1 comments

Forbes William P 🟡 adjusted position in 0 shares (1 derivative) of HERON THERAPEUTICS, INC. /DE/ (HRTX) Transaction Date: Apr 19, 2026 | Filing ID: 165591

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 21, 2026, 15:10 UTC
  • 2
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001193125-26-166172 <b>Size:</b> 439 KB

Comment Full text

MARVELL TECHNOLOGY, INC. (MRVL)

  • SEC News
  • April 21, 2026, 15:10 UTC
  • 2
  • 1 comments

Casper Mark 🔴 sold 10.0K shares of Marvell Technology, Inc. (MRVL) at $135.50 ($1.4M) Transaction Date: Apr 17, 2026 | Filing ID: 026152

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 21, 2026, 15:08 UTC
  • 2
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001193125-26-166169 <b>Size:</b> 446 KB

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • April 21, 2026, 15:07 UTC
  • 2
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001839882-26-020761 <b>Size:</b> 341 KB

Comment Full text

BEYOND MEAT, INC. (BYND)

  • SEC News
  • April 21, 2026, 15:07 UTC
  • 2
  • 0 comments

New Form 144/A - BEYOND MEAT, INC. <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001628280-26-026206 <b>Size:</b> 27 KB

Comment Full text

GOLDMAN SACHS GROUP INC (GS)

  • SEC News
  • April 21, 2026, 15:06 UTC
  • 2
  • 0 comments

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001193125-26-166155 <b>Size:</b> 367 KB

Comment Full text
  • Previous
  • 933
  • 934
  • 935
  • 936
  • 937
  • Next

Search

News categories

  • Technical Exchange News(12117)
  • Event(5560)
  • SEC News(254504)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(151578)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin